Alan S. Lowenthal sold Orexigen Therapeutics, Inc. (OREX) (OREX)
Alan S. Lowenthal (D-CA), a U.S. Representative, has disclosed 1 trade in Orexigen Therapeutics, Inc. (OREX) (OREX) since 2018, a single sale, worth an estimated $55 in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Alan S. Lowenthal sold $11.99 of Orexigen Therapeutics, Inc. (OREX) (OREX) on January 5, 2018. Since that trade, OREX is up +0.00% against the S&P 500 up +203.12%, an outperformance of -203.12%.
Data updated
Alan S. Lowenthal's OREX trades vs the price
OREX is up +0.00% since Alan S. Lowenthal sold on January 5, 2018, versus +203.12% for the S&P 500.
Performance since this trade
All Alan S. Lowenthal OREX trades
Alan S. Lowenthal & OREX trading FAQ
Is it legal for Alan S. Lowenthal to trade Orexigen Therapeutics, Inc. (OREX) (OREX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Orexigen Therapeutics, Inc. (OREX) (OREX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Alan S. Lowenthal sell OREX?
Alan S. Lowenthal disclosed a sale of $11.99 of Orexigen Therapeutics, Inc. (OREX) (OREX) on January 5, 2018, according to public STOCK Act filings.
How has OREX performed since Alan S. Lowenthal's trade?
Since Alan S. Lowenthal sold OREX on January 5, 2018, the stock is up +0.00%, versus +203.12% for the S&P 500 over the same period, an outperformance of -203.12%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional OREX trades?
Quantellect tracks every disclosed congressional trade in Orexigen Therapeutics, Inc. (OREX) (OREX) on the Orexigen Therapeutics, Inc. (OREX) congressional trading page, which aggregates filings across all members of Congress.
Alan S. Lowenthal's OREX tradesAll congressional filings for Orexigen Therapeutics, Inc. (OREX)Alan S. Lowenthal's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.